The potential use of influenza virus as an agent for bioterrorism

Antiviral Research

Volumn 57, Issue 1-2, 2003, Pages 147-150

  Krug, Robert M ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Antiviral drugs; H5N1 viruses; Influenza A virus; Reverse genetics

Indexed keywords

ANTIVIRUS AGENT; RNA DIRECTED RNA POLYMERASE; VIRUS RNA; VIRUS VACCINE;

ANTIVIRAL ACTIVITY; BIOLOGICAL CONTROL AGENT; BIOLOGICAL WARFARE; DNA TRANSFECTION; DRUG MECHANISM; EPIDEMIC; HELPER VIRUS; HONG KONG; HUMAN; IMMUNOPHARMACOLOGY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS INDUCTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0037282358     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(02)00207-3     Document Type: Article

References (32)

1. Air G.M., Ghate A.A., Stray S.J. Influenza neuraminidase as target for antivirals. Adv. Virus Res. 54:1999;375-402.
2. Chaubey A., Malhotra B.D. Mediated biosensors. Biosens. Bioelectron. 17:2002;441-456.
3. Chen Z., Li Y., Krug R.M. Influenza A virus NS1 protein targets poly(A) binding protein II of the cellular 3′-end processing machinery. EMBO J. 18:1999;2273-2283.
4. Cianci C., Tiley L., Krystal M. Differential activation of the influenza virus polymerase via template RNA binding. J. Virol. 69:1995;3995-3999.
5. Claas E.C., Osterhaus A.D., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K.F., Webster R.G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 351:1998;472-477.
6. Fodor E., Devenish L., Engelhardt O.G., Palese P., Brownlee G.G., Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol. 73:1999;9679-9682.
7. Francis T. Transmission of influenza by a filterable virus. Science. 80:1934;457-459.
8. Hagen M., Chung T.D.Y., Butcher A., Krystal M. Recombinant influenza virus polymerase: requirement of both 5′ and 3′ viral ends for endonuclease activity. J Virol. 68:1994;1509-1515.
9. Hatta M., Gao P., Halfmann P., Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 293:2001a;1840-1842.
10. Hatta M., Neumann G., Kawaoka Y. Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:2001b;1841-1843.
11. Hay A.J., Wolstenholme A.J., Skehel J.J., Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:1985;3021-3024.
12. Kim M.J., Latham A.G., Krug R.M. Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10096-10101.
13. Krug, R.M., Alonso-Caplen, F.V., Julkunen, I., Katze, M., 1989. Expression and replication of the influenza virus genome. In: Krug, R.M. (Ed.), The Influenza Viruses. Plenum Press, New York, pp. 89-152.
14. Lamb, R.A., Krug, R.M., 2001. Orthomyxoviridae: the viruses and their replication. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 1487-1532.
15. Li M.-L., Ramirez C., Krug R.M. RNA-dependent activation of primer RNA production by the influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA-binding sites. EMBO J. 17:1998;5844-5852.
16. Li M.-L., Rao P., Krug R.M. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J. 20:2001;2078-2086.
17. Li Y., Chen Z.Y., Wang W., Baker C.C., Krug R. The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA. 7:2001;920-931.
18. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., Hughes M., Perez D.R., Donis R., Hoffmann E., Hobom G., Kawaoka Y. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9345-9350.
19. Nemeroff M., Barabino S.M.L., Keller W., Krug R.M. Influenza virus NS1 protein interacts with the 30 kD subunit of cleavage and specificity factor and inhibits 3′-end formation of cellular pre-mRNAs. Mol. Cell. 1:1998;991-1000.
20. Osterhaus A.D., Rimmelzwaan G.F., Martina B.E., Bestebroer T.M., Fouchier R.A. Influenza B virus in seals. Science. 288:2000;1051-1053.
21. O'Sullivan C.K. Aptasensors - the future of biosensing? Anal. Bioanal. Chem. 372:2002;44-48.
22. Pinto L.H., Holsinger L.J., Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell. 69:1992;517-528.
23. Reid A.H., Taubenberger J.K., Fanning T.G. The 1918 Spanish influenza: integrating history and biology. Microbes Infect. 3:2001;81-87.
24. Scheller F.W., Wollenberger U., Warsinke A., Lisdat F. Research and development in biosensors. Curr. Opin. Biotechnol. 12:2001;35-40.
25. Smith W., Andrewes C., Laidlaw P. A virus obtained from influenza patients. Lancet. 225:1933;66-68.
26. Suarez D.L., Perdue M.L., Cox N., Rowe T., Bender C., Huang J., Swayne D.E. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 72:1998;6678-6688.
27. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., Perdue M., Swayne D., Bender C., Huang J., Hemphill M., Rowe T., Shaw M., Xu X., Fukuda K., Cox N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 279:1998;393-396.
28. 7 GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2, 4-dioxobutanoic acid compounds. Antimicrob. Agents Chemother. 38:1994;2827-2837.
29. Tomassini J.E., Davies M.E., Hastings J.C., Lingham R., Mojena M., Raghoobar S.L., Singh S.B., Tkacz J.S., Goetz M.A. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob. Agents Chemother. 40:1996;1189-1193.
30. Webster R.G., Guan Y., Peiris M., Walker D., Krauss S., Zhou N.N., Govorkova E.A., Ellis T.M., Dyrting K.C., Sit T., Perez D.R., Shortridge K.F. Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J. Virol. 76:2002;118-126.
31. Wright, P.F., Webster, R.G., 2001. Orthomyxoviruses. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 1533-1579.
32. Yuen K.Y., Chan P.K., Peiris M., Tsang D.N., Que T.L., Shortridge K.F., Cheung P.T., To W.K., Ho E.T., Sung R., Cheng A.F. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 351:1998;467-471.